ImmunityBio, Inc. (IBRX)
NASDAQ: IBRX · Real-Time Price · USD
7.32
+0.07 (0.97%)
At close: Aug 6, 2026, 4:00 PM EDT
7.33
+0.01 (0.14%)
After-hours: Aug 6, 2026, 7:59 PM EDT
ImmunityBio Market Cap
ImmunityBio has a market cap or net worth of $7.76 billion as of August 6, 2026. Its market cap has increased by 240.55% in one year.
Market Cap
7.76B
Enterprise Value
8.63B
1-Year Change
240.55%
Ranking
Category
Stock Price
$7.32
ChartMarket Cap Chart
Since March 10, 2021, ImmunityBio's market cap has decreased from $14.82B to $7.76B, a decrease of -47.66%. That is a compound annual growth rate of -11.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 7.76B | 297.80% |
| Dec 31, 2025 | 1.95B | 4.33% |
| Dec 31, 2024 | 1.87B | -44.23% |
| Dec 29, 2023 | 3.35B | 61.49% |
| Dec 30, 2022 | 2.08B | -14.18% |
| Dec 31, 2021 | 2.42B | -83.68% |
| Mar 10, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Crinetics Pharmaceuticals | 8.83B |
| Praxis Precision Medicines | 8.52B |
| Protagonist Therapeutics | 8.51B |
| Spyre Therapeutics | 8.35B |
| Kymera Therapeutics | 8.25B |
| Immunovant | 7.95B |
| Vaxcyte | 7.73B |
| Rhythm Pharmaceuticals | 7.04B |